Skip to main content
Skip to section navigation
Skip to footer
Home
About Us
Our Leadership
Our Science
Introduction to
FcRn
Pipeline & Therapeutic Areas
Patients & Caregivers
Our Commitment
Therapeutic Areas & Clinical Trials
For Investors
Overview
News & Events
Company Info
Financials
Stock Data
SEC Filings
Governance
Join Us
Values & Culture
Explore Careers
Contact Us
IR Calendar
View Main Content
For Investors
For Investors
Overview
News & Events
Overview
Press Releases
IR Calendar
Presentations
Email Alerts
Company Info
Overview
Executive Leadership Team
Contacts
FAQ
Financials
Overview
Financial Results
Income Statement
Balance Sheet
Cash Flow
Stock Data
Quote
Charts
Historical Data
Analyst Coverage
SEC Filings
Overview
All SEC Filings
Governance
Overview
Board of Directors
Board Committees
Governance Documents
Whistleblower Policy
Immunovant Development Update Call
March 19, 2025 8:00 am EDT
Webcast
Audio
Email Alerts
Contacts
RSS News Feed